Skip to main content

News and blog posts

Jul 2023

Rapid HTAs of nine medical devices released in Tuscany

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 13989 of June 29, 2023, Tuscany Regional Healthcare has published assessments of nine medical devices in the cardiovascular, peripheral vascular, diagnostic imaging areas, and surgical procedures.
Jul 2023

Extended reimbursement for next-generation sequencing (NGS) in Belgium

In late June 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) decided to extend reimbursement for molecular biology tests by next-generation sequencing (NGS) for one year until June 30, 2024. NGS in oncology and hemato-oncology are temporarily reimbursed as a pilot under a specific agreement (Convention) with INAMI-RIZIV from 2019.
Jul 2023

Recommendations about add-on reimbursement for medical devices in France in June 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in June 2023. Twenty-eight recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular and peripheral vascular, endocrine, ENT, orthopedic, spinal, and surgical devices, as well as medical aids.
Jul 2023

MTRC welcomes Health Economist Dharna Gupta to the team

We are happy to announce the further expansion of our HEOR Department with Dr. Dharna Gupta, a dentist by training and a Health Economist by profession. Dharna holds a Master of Public Health degree in Health Policy, Economics & Finance from the Tata Institute of Social Sciences, Mumbai, India (2020). Dharna is a public health researcher with expertise in health systems and policy research, costing analysis, health economic modeling, economic evaluations, and value-based pricing in governmental settings. For the past three years, she was part of the HTA team at the Postgraduate Institute of Medical Education & Research, India, where she has worked on health economic models in the field of oncology, policy briefs and treatment guidelines at the state and national levels, and contributed to the educational modules on evidence-based medicine and health economics. If you are interested in learning about our capabilities in evidence synthesis, please, reach out to us to arrange a call to discuss your needs.
Jul 2023

MedTech-related technology assessments and clinical guidelines from NICE in June 2023

In June 2023, the National Institute for Health and Care Excellence (NICE) published five new Interventional Procedure Guidance (intraoperative electron beam radiotherapy, minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis, endoscopic ultrasound-guided gallbladder drainage, radiofrequency denervation for osteoarthritic knee pain, and Botulinum toxin type A injections into the urethral sphincter), two new Diagnostic Guidance (transperineal biopsy for prostate cancer, and FibroScan for liver fibrosis and cirrhosis), and two Medtech Innovation Briefings (MiraQ cardiac TTFM, Proov Confirm; their development started before April 2023). Also, four clinical guidelines were updated.
Jul 2023

The 2024 DRG model announced in Austria

On July 3, 2023, the document "Changes and innovations in the 2024 LKF model" (Änderungen und Neuerungen in den LKF-Modellen 2024) was published. The document summarizes the most significant changes and innovations in the LKF model for inpatient and outpatient care. The newly added procedure codes mainly concern endoscopic procedures, orthopedics, peripheral vascular, and pulmonary and airways fields.
Jul 2023

Publication Digest: The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE's New Methods Manual

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Angelis et al. appraised the methodological changes proposed by the National Institute for Health and Care Excellence (NICE) in their recent review of HTA methods. The authors categorized proposed changes as critical, moderate, or limited updates and analyzed key decisions. The study found that most changes were appropriate and had a modest impact, although some decisions lacked justification. The authors emphasize the need for further research on certain topics and the importance of safeguarding NICE's role in resource allocation for valuable interventions while maintaining rigorous evidence standards.
Jul 2023

Publication Digest: The impact of different types of NHS expenditure on health: Marginal cost per QALY estimates for England for 2016/17

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Martin et al. calculated the marginal cost per quality-adjusted life year (QALY) for different categories of care (primary care, locally commissioned secondary care, specialised services) using the data from 2016 and analysed the mortality response to healthcare expenditure on the three categories of care. The results revealed that additional investments in primary care and locally commissioned services are likely the most productive, suggesting the potential benefits of directing resources towards these categories of care.